The teams in RheumMadness 2025, the Innovation Invitational were proposed by 67 collaborators (20 attendings, 35 fellows, 5 residents, 5 medical students, 2 “other”) from 21 different institutions around the world. Together, these amazing people have written fun and informative scouting reports that will draw attention to some of the latest and greatest innovations in rheumatology, and we can’t wait to share them with you!
Region 1: T’d Up T Cells
- CD40L inhibitor in Sjogren’s, by trainees associated with the Duke Adult Rheumatology Fellowship
- Abatacept in pre-RA, by the Allegheny Health Network Adult Rheumatology Fellowship
- Bispecific T-cell engagers (BiTEs), by Marwin Groener and Maximilian F. Konig from the Johns Hopkins University School of Medicine
Region 2: Cytokine Crushers
- Oral anti-IL23, by collaborating Chicago area rheumatology fellowship programs (Loyola, Northwestern, and the University of Chicago)
- Long-term outcomes of anifrolumab in SLE, by the Medical University of South Carolina (MUSC) Adult Rheumatology Fellowship
- TYK2 inhibitor in SLE, by the University of North Carolina (UNC) Adult Rheumatology Fellowship
Region 3: Full-Court Care Champions
- Cost-effectiveness of hydroxychloroquine retinopathy screening, by residents from the Lankenau Medical Center Internal Medicine Residency Program
- Steroid dose in lupus nephritis, by the Washington University in St. Louis (WUSTL) Adult Rheumatology Fellowship Program
- SGCAPS prediction tool, by the Medical College of Wisconsin Adult Rheumatology Fellowship Program.
Region 4: B-Cell Breakaway
- STRAP trial, by the Emerging EULAR Network (EMEUNET)
- Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship Program
- CD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship Program
Scouting Report Archive
Looking to find your favorite scouting report from a prior year? See links below.
RheumMadness 2021: Let the Madness Begin
RheumMadness 2022: Planet of the Rheumatologists
